Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001178913-11-001379
Filing Date
2011-05-16
Accepted
2011-05-16 06:12:34
Documents
1
Effectiveness Date
2011-05-16

Document Format Files

Seq Description Document Type Size
1 DEFA 14A zk1109882.htm DEFA14A 54945
  Complete submission text file 0001178913-11-001379.txt   56210
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-31392 | Film No.: 11843285
SIC: 2836 Biological Products, (No Diagnostic Substances)